Stryker Corporation
Stryker Corporation Announces New Revolving Credit Agreement
Summary
Stryker Corporation announced on February 25, 2025, that it has entered into a new revolving credit agreement replacing its previous agreement dated October 26, 2021. The new agreement provides for an aggregate principal amount of commitments of $3.0 billion, with a maturity date of February 25, 2030. The agreement also includes a leverage ratio financial covenant and an annual facility fee dependent on the company's credit ratings. A copy of the Credit Agreement is furnished as Exhibit 10.1.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement